Leadership is about fostering the conditions for others to succeed. Empathy shapes how teams function, how trust is built, ...

Improvements to the U.S. supply chain are needed to reduce shortages and protect American patients. Industry, academia, ...

Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

For many professionals in the drug development industry, cell and gene therapies (CGT) represent a beacon of hope for patients in dire need of innovative treatments. This rapidly evolving field is ...

Business of Biotech MVP Allan Shaw is back to talk about the rise of China's biotech sector, and its evolution from fast follower to global innovation powerhouse.

In healthcare, product launches tend to take on a life of their own. The buildup, the planning, and the expectations all revolve around that single moment when a product finally reaches the market.

On today's episode of the Business of Biotech, we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to ...

With the recent sign-off from the FDA on protocols for a pivotal Phase 3 trial of IMNN-001 in advanced ovarian cancer, Imunon is poised to bring its IL-12 DNA plasmid vector (encased in a nanoparticle ...

As the fentanyl epidemic rages on, opioid antagonist rescue agents like Narcan, Kloxxado, and Opvee have become omnipresent. Like defibrillators and EpiPens, advocates insist they should be available ...

Leadership in pharma involves fostering a culture where everyone can thrive. This means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are ...